NIH-funded research R01 grant

Using artificial intelligence to analyze heart imaging for understanding cardiovascular stress in older adults

Official title: Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress

Funded at Cedars-Sinai Medical Center · NIH-11048345 · Data updated 2026-11-12

This study is exploring how smart computer technology can help doctors look at heart images more closely to spot early signs of heart problems in older adults, which could lead to better care and treatment just for you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startDecember 12, 2024
Project endJanuary 31, 2025
Funding year2025
Award (this year)$1
NIH project number1R01HL173487-01A1
Project IDNIH-11048345 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults aged 65 and older who are at risk for cardiovascular disease.

Less likely to help

Patients under the age of 65 or those without cardiovascular risk factors may not receive direct benefits from this research.

What this research studies

This research investigates how artificial intelligence can enhance the analysis of heart imaging to better understand cardiovascular stress, particularly in older adults. By utilizing advanced deep learning algorithms, the study aims to identify subtle changes in cardiac structure and function that may indicate increased cardiovascular risk. The approach focuses on tracking these changes over time, providing insights into the relationship between biological and chronological age. Patients may benefit from improved risk assessment and personalized treatment strategies based on their unique cardiovascular profiles.

Why it matters

Potential benefit: If successful, this research could lead to more accurate assessments of cardiovascular risk in older adults, enabling earlier interventions and better management of heart health.

How similar studies have gone: Previous studies have shown success in applying artificial intelligence to medical imaging, indicating a promising avenue for advancing cardiovascular risk assessment.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Ouyang, David — Cedars-Sinai Medical Center
  • Study coordinator: Ouyang, David

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.